Cite
MLA Citation
Thomas Urup et al.. “Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma.” Molecular oncology, vol. 14, no. 5, 2020, pp. 964–973. http://access.bl.uk/ark:/81055/vdc_100102664495.0x00000f